These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 9605137

  • 1. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter.
    Parra E, McGuire K, Hedlund G, Dohlsten M.
    J Immunol; 1998 Jun 01; 160(11):5374-81. PubMed ID: 9605137
    [Abstract] [Full Text] [Related]

  • 2. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
    McGuire KL, Iacobelli M.
    J Immunol; 1997 Aug 01; 159(3):1319-27. PubMed ID: 9233628
    [Abstract] [Full Text] [Related]

  • 3. Costimulation of human CD4+ T cells with LFA-3 and B7 induce distinct effects on AP-1 and NF-kappa B transcription factors.
    Parra E, Varga M, Sigvardsson M, Hedlund G, Kalland T, Leanderson T, Sjögren HO, Dohlsten M.
    J Immunol; 1995 Aug 01; 155(3):1132-40. PubMed ID: 7543515
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Costimulation of human CD4+ T lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles.
    Parra E, Wingren AG, Hedlund G, Björklund M, Sjögren HO, Kalland T, Sansom D, Dohlsten M.
    J Immunol; 1994 Sep 15; 153(6):2479-87. PubMed ID: 7521363
    [Abstract] [Full Text] [Related]

  • 6. Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT DNA binding.
    Parra E, Varga M, Hedlund G, Kalland T, Dohlsten M.
    Mol Cell Biol; 1997 Mar 15; 17(3):1314-23. PubMed ID: 9032258
    [Abstract] [Full Text] [Related]

  • 7. Costimulation of peripheral blood T cell activation by human endothelial cells. Enhanced IL-2 transcription correlates with increased c-fos synthesis and increased Fos content of AP-1.
    Hughes CC, Pober JS.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3148-60. PubMed ID: 8468462
    [Abstract] [Full Text] [Related]

  • 8. CD28 costimulation augments IL-2 secretion of activated lamina propria T cells by increasing mRNA stability without enhancing IL-2 gene transactivation.
    Gonsky R, Deem RL, Lee DH, Chen A, Targan SR.
    J Immunol; 1999 Jun 01; 162(11):6621-9. PubMed ID: 10352279
    [Abstract] [Full Text] [Related]

  • 9. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.
    Lai JH, Horvath G, Subleski J, Bruder J, Ghosh P, Tan TH.
    Mol Cell Biol; 1995 Aug 01; 15(8):4260-71. PubMed ID: 7623820
    [Abstract] [Full Text] [Related]

  • 10. Calcineurin activates transcription from the GM-CSF promoter in synergy with either protein kinase C or NF-kappa B/AP-1 in T cells.
    Tsuboi A, Muramatsu M, Tsutsumi A, Arai K, Arai N.
    Biochem Biophys Res Commun; 1994 Mar 15; 199(2):1064-72. PubMed ID: 8135780
    [Abstract] [Full Text] [Related]

  • 11. IL-2-independent activation and proliferation in human T cells induced by CD28.
    Boulougouris G, McLeod JD, Patel YI, Ellwood CN, Walker LS, Sansom DM.
    J Immunol; 1999 Aug 15; 163(4):1809-16. PubMed ID: 10438913
    [Abstract] [Full Text] [Related]

  • 12. Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation involves both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals.
    Edmead CE, Patel YI, Wilson A, Boulougouris G, Hall ND, Ward SG, Sansom DM.
    J Immunol; 1996 Oct 15; 157(8):3290-7. PubMed ID: 8871623
    [Abstract] [Full Text] [Related]

  • 13. Identification of a CD28 response element in the CD40 ligand promoter.
    Parra E, Mustelin T, Dohlsten M, Mercola D.
    J Immunol; 2001 Feb 15; 166(4):2437-43. PubMed ID: 11160303
    [Abstract] [Full Text] [Related]

  • 14. The Jun kinase cascade is responsible for activating the CD28 response element of the IL-2 promoter: proof of cross-talk with the I kappa B kinase cascade.
    Kempiak SJ, Hiura TS, Nel AE.
    J Immunol; 1999 Mar 15; 162(6):3176-87. PubMed ID: 10092768
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF, Wang Y, Cho JY, Libermann TA.
    Cancer Res; 2003 May 01; 63(9):2206-15. PubMed ID: 12727841
    [Abstract] [Full Text] [Related]

  • 17. Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors.
    Ott M, Lovett JL, Mueller L, Verdin E.
    J Immunol; 1998 Mar 15; 160(6):2872-80. PubMed ID: 9510190
    [Abstract] [Full Text] [Related]

  • 18. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
    Stütz AM, Woisetschläger M.
    J Immunol; 1999 Oct 15; 163(8):4383-91. PubMed ID: 10510379
    [Abstract] [Full Text] [Related]

  • 19. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S, Manabe N, Kubota Y, Ohnishi H, Kitanaka A, Tokuda M, Taminato T, Ishida T, Takahara J, Tanaka T.
    Int Immunopharmacol; 2005 Apr 15; 5(4):699-710. PubMed ID: 15710339
    [Abstract] [Full Text] [Related]

  • 20. The role of B7-1 and LFA-3 in costimulation of CD8+ T cells.
    Parra E, Wingren AG, Hedlund G, Kalland T, Dohlsten M.
    J Immunol; 1997 Jan 15; 158(2):637-42. PubMed ID: 8992978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.